logo

SKU: 188-10436-SAF-RB

Anti-HLA-DR Antibody (MHC II), Sodium Azide Free

Blue Ice

Specifications

Specification Details
Species Reactivity Human, Monkey
Application Flow Cytometry, Immunofluorescence
Label Unconjugated
Gene ID 3122
Accession No. P01903
Immunogen Spleen cells from a patient with hairy cell leukemia were used as the immunogen for the HLA-DR antibody.
Background mAb IPO-1 defines the antigen, which appears on B cell progenitors following HLA-DR and preceding CD1, CD19, CD22, CD37 and cym. It is expressed on resting B cells and than reappears and persists in cytoplasm and on cell surface until cytoplasmic Ig appears. It is a useful antibody for diagnostics of neoplasms of B cell origins. It reacts with human B cell lines Daudi, Raji, Namalva, EB-3, RPMI-8226 (5% of cells). The mAb does not label T cell lines, blood granulocytes, thymocytes or bone marrow stromal fibroblasts. No significant changes are detected after PHA or ConA stimulation while LPS and PWM stimulated cultures after 18-48h show decreased number of antigen-positive cells but in final terms of cultivation antigen is expressed again. This mAb labels B cell leukemias and some lymphomas. Hairy cell leukemia strongly reacts and 7% of B cell CLL and some B-NHL were also positive. IPO-1 reacts with AMML cells and in a majority of Hodgkin's disease cases a significant percentage of affected lymph node cells were detected.
Primary / Secondary Primary Antibody
Isotype Mouse IgG3, kappa
Concentration 1 mg/ml in 1X PBS, BSA free, sodium azide free
Host Mouse
Catalog Number
188-10436-SAF-RB
Name
Anti-HLA-DR Antibody (MHC II), Sodium Azide Free
Price(100 ug)
Pack Size
100 ug
← Back to products